Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04633239
Title Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
Recruitment Suspended
Gender female
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)

ovary epithelial cancer


Abemaciclib + Olaparib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.